Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
American Journal of Clinical Oncology
|
February 1, 1996
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer
C Erlichman, S Fine, I Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer
P Preusser, H Wilke, W Achterrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma
A Harstrick, C H Köhne, W Hiddemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus
M Stahl, H Wilke, H J Meyer, et al.
Investigational New Drugs
|
February 1, 1990
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk
H Wilke, P Preusser, U Fink, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus
A Harstrick, C Bokemeyer, P Preusser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin
H Wilke, P Preusser, U Fink, et al.
Seminars in Oncology
|
February 1, 1990
New developments in the treatment of gastric carcinoma
H Wilke, P Preusser, U Fink, et al.
Cancer Treatment and Research
|
January 1, 1991
New developments in the treatment of gastric carcinoma
H Wilke, P Preusser, U Fink, et al.
British Journal of Cancer
|
January 1, 1997
Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study
F J Prott, K Schönekaes, P Preusser, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
American Journal of Clinical Oncology
|
February 1, 1996
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancer
C Erlichman, S Fine, I Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer
P Preusser, H Wilke, W Achterrath, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 14, 1997
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma
A Harstrick, C H Köhne, W Hiddemann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus
M Stahl, H Wilke, H J Meyer, et al.
Investigational New Drugs
|
February 1, 1990
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk
H Wilke, P Preusser, U Fink, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus
A Harstrick, C Bokemeyer, P Preusser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin
H Wilke, P Preusser, U Fink, et al.
Seminars in Oncology
|
February 1, 1990
New developments in the treatment of gastric carcinoma
H Wilke, P Preusser, U Fink, et al.
Cancer Treatment and Research
|
January 1, 1991
New developments in the treatment of gastric carcinoma
H Wilke, P Preusser, U Fink, et al.
British Journal of Cancer
|
January 1, 1997
Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study
F J Prott, K Schönekaes, P Preusser, et al.
Page
of 5